This trial is testing the impact of exercise intensity on the hormone ghrelin, as well as how changes in ghrelin from exercise affect obesity, insulin sensitivity, and vascular function.
- Insulin Resistance
- Cardiovascular Risk
1 Primary · 2 Secondary · Reporting Duration: Insulin and glucose will be collected at 5 timepoints during the OGTT, and 11 timepoints during each testing visit. The Matsuda index (mathematical model) will be used to calculate insulin sensitivity
3 Treatment Groups
1 of 3
Moderate Intensity Exercise
1 of 3
High Intensity Exercise
1 of 3
80 Total Participants · 3 Treatment Groups
Primary Treatment: Exercise · No Placebo Group · N/A
Who is running the clinical trial?
Age 40 - 55 · All Participants · 5 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Is enrollment in this medical trial open to individuals aged twenty-five or older?
"This medical study seeks patients aged 40 to 55 for its clinical trial. Additionally, there are 220 trials that admit applicants below 18 years of age and 725 studies open to people 65 or older." - Anonymous Online Contributor
Is enrollment for this trial still open?
"As shown on the clinicaltrials.gov website, this trial is still actively recruiting participants who are willing to take part in it. This research project was initially posted on October 14th 2020 and underwent its most recent update on May 13th 2022." - Anonymous Online Contributor
Do I fulfill the qualifications for participation in this clinical experimentation?
"This medical trial has a target of 80 participants who must be between 40 and 55 years old, with insulin resistance as the primary qualification." - Anonymous Online Contributor
How many people have signed up to partake in this research?
"Affirmative. The information on clinicaltrials.gov affirms that this research is currently accepting participants. This study was unveiled on October 14th 2020 and the latest update was made on May 13th 2022, with a requirement of 80 patients across 1 medical facility." - Anonymous Online Contributor